JP2015520163A5 - - Google Patents

Download PDF

Info

Publication number
JP2015520163A5
JP2015520163A5 JP2015512831A JP2015512831A JP2015520163A5 JP 2015520163 A5 JP2015520163 A5 JP 2015520163A5 JP 2015512831 A JP2015512831 A JP 2015512831A JP 2015512831 A JP2015512831 A JP 2015512831A JP 2015520163 A5 JP2015520163 A5 JP 2015520163A5
Authority
JP
Japan
Prior art keywords
growth factor
soluble polymer
factor
protein
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015512831A
Other languages
English (en)
Japanese (ja)
Other versions
JP6195611B2 (ja
JP2015520163A (ja
Filing date
Publication date
Priority claimed from US13/488,043 external-priority patent/US8809501B2/en
Application filed filed Critical
Priority claimed from PCT/US2013/041280 external-priority patent/WO2013173543A1/en
Publication of JP2015520163A publication Critical patent/JP2015520163A/ja
Publication of JP2015520163A5 publication Critical patent/JP2015520163A5/ja
Application granted granted Critical
Publication of JP6195611B2 publication Critical patent/JP6195611B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015512831A 2012-05-16 2013-05-16 オキシム連結のための求核触媒 Active JP6195611B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261647814P 2012-05-16 2012-05-16
US61/647,814 2012-05-16
US13/488,043 2012-06-04
US13/488,043 US8809501B2 (en) 2009-07-27 2012-06-04 Nucleophilic catalysts for oxime linkage
PCT/US2013/041280 WO2013173543A1 (en) 2012-05-16 2013-05-16 Nucleophilic catalysts for oxime linkage

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017109323A Division JP6560712B2 (ja) 2012-05-16 2017-06-01 オキシム連結のための求核触媒

Publications (3)

Publication Number Publication Date
JP2015520163A JP2015520163A (ja) 2015-07-16
JP2015520163A5 true JP2015520163A5 (cg-RX-API-DMAC7.html) 2016-09-01
JP6195611B2 JP6195611B2 (ja) 2017-09-13

Family

ID=48579473

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2015512831A Active JP6195611B2 (ja) 2012-05-16 2013-05-16 オキシム連結のための求核触媒
JP2017109323A Active JP6560712B2 (ja) 2012-05-16 2017-06-01 オキシム連結のための求核触媒
JP2019018663A Active JP6711935B2 (ja) 2012-05-16 2019-02-05 オキシム連結のための求核触媒
JP2020067396A Active JP7014844B2 (ja) 2012-05-16 2020-04-03 オキシム連結のための求核触媒
JP2021215385A Active JP7304402B2 (ja) 2012-05-16 2021-12-29 オキシム連結のための求核触媒

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2017109323A Active JP6560712B2 (ja) 2012-05-16 2017-06-01 オキシム連結のための求核触媒
JP2019018663A Active JP6711935B2 (ja) 2012-05-16 2019-02-05 オキシム連結のための求核触媒
JP2020067396A Active JP7014844B2 (ja) 2012-05-16 2020-04-03 オキシム連結のための求核触媒
JP2021215385A Active JP7304402B2 (ja) 2012-05-16 2021-12-29 オキシム連結のための求核触媒

Country Status (12)

Country Link
EP (3) EP4019049A1 (cg-RX-API-DMAC7.html)
JP (5) JP6195611B2 (cg-RX-API-DMAC7.html)
KR (4) KR102287040B1 (cg-RX-API-DMAC7.html)
CN (2) CN109620963B (cg-RX-API-DMAC7.html)
AU (1) AU2013204754C1 (cg-RX-API-DMAC7.html)
BR (1) BR112014028636B1 (cg-RX-API-DMAC7.html)
CA (1) CA2873756C (cg-RX-API-DMAC7.html)
EA (2) EA035506B1 (cg-RX-API-DMAC7.html)
MX (1) MX360594B (cg-RX-API-DMAC7.html)
NZ (4) NZ738844A (cg-RX-API-DMAC7.html)
SG (3) SG10201911328QA (cg-RX-API-DMAC7.html)
WO (2) WO2013173557A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013204754C1 (en) * 2012-05-16 2018-10-11 Takeda Pharmaceutical Company Limited Nucleophilic Catalysts for Oxime Linkage
CN109963579A (zh) * 2016-11-14 2019-07-02 诺华股份有限公司 用于治疗软骨损伤和关节炎的方法和组合物
JP7002036B2 (ja) * 2016-11-17 2022-01-20 パナソニックIpマネジメント株式会社 膜電極接合体および固体酸化物形燃料電池
US11786586B2 (en) 2016-12-23 2023-10-17 Aoa Dx Carbohydrate structures and uses thereof
CN108503901B (zh) * 2018-04-17 2020-07-07 哈尔滨工业大学 一种抗菌普鲁兰多糖/壳聚糖复合食品包装膜的制备方法
US11845989B2 (en) 2019-01-23 2023-12-19 Regeneron Pharmaceuticals, Inc. Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
CA3126476A1 (en) 2019-01-23 2020-07-30 Regeneron Pharmaceuticals, Inc. Treatment of ophthalmic conditions with angiopoietin-like 7 (angptl7) inhibitors
WO2022182768A1 (en) 2021-02-26 2022-09-01 Regeneron Pharmaceuticals, Inc. Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (angptl7) inhibitors
WO2023171638A1 (ja) 2022-03-07 2023-09-14 株式会社カネカ グルタチオンを含む粒状組成物の製造方法
WO2025133203A1 (en) * 2023-12-22 2025-06-26 Pam Theragnostics Gmbh Compounds and methods for a long-lasting pam

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54113492A (en) 1978-02-24 1979-09-05 Sanyo Chem Ind Ltd Preparation of glucoprotein derivative
US4356170A (en) 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4757006A (en) 1983-10-28 1988-07-12 Genetics Institute, Inc. Human factor VIII:C gene and recombinant methods for production
US5198349A (en) 1986-01-03 1993-03-30 Genetics Institute, Inc. Method for producing factor VIII:C and analogs
US5250421A (en) 1986-01-03 1993-10-05 Genetics Institute, Inc. Method for producing factor VIII:C-type proteins
JPH0387173A (ja) 1987-09-10 1991-04-11 Teijin Ltd ヒト活性化天然型ファクター8cの製造方法及びそれに用いる形質転換体
US5846951A (en) 1991-06-06 1998-12-08 The School Of Pharmacy, University Of London Pharmaceutical compositions
ATE198277T1 (de) 1992-10-02 2001-01-15 Genetics Inst Zusammensetzung, welche den koagulationsfaktor viii beinhaltet; verfahren zu deren herstellung und die benutzung eines oberflächenaktiven stoffes als stabilisator
NZ250375A (en) * 1992-12-09 1995-07-26 Ortho Pharma Corp Peg hydrazone and peg oxime linkage forming reagents and protein derivatives
WO1994028024A1 (en) * 1993-06-01 1994-12-08 Enzon, Inc. Carbohydrate-modified polymer conjugates with erythropoietic activity
US5621039A (en) 1993-06-08 1997-04-15 Hallahan; Terrence W. Factor IX- polymeric conjugates
WO1996040662A2 (en) 1995-06-07 1996-12-19 Cellpro, Incorporated Aminooxy-containing linker compounds and their application in conjugates
WO1999003496A1 (en) 1997-07-21 1999-01-28 The University Of North Carolina At Chapel Hill Factor ix antihemophilic factor with increased clotting activity
US7074878B1 (en) 1999-12-10 2006-07-11 Harris J Milton Hydrolytically degradable polymers and hydrogels made therefrom
US6413507B1 (en) 1999-12-23 2002-07-02 Shearwater Corporation Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)
AU2001258536A1 (en) 2000-05-16 2001-11-26 Lipoxen Technologies Limited Derivatisation of proteins in aqueous solution
US7265084B2 (en) 2001-10-10 2007-09-04 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
EP1446438A2 (en) 2001-11-07 2004-08-18 Nektar Therapeutics Al, Corporation Branched polymers and their conjugates
MXPA05002594A (es) 2002-09-11 2005-05-27 Fresenius Kabi Gmbh Derivados de polipeptidos con hidroxialquilalmidon, especialmente derivados de eritropoyetina con hidroxialquilalmidon.
WO2004089280A2 (en) 2003-04-08 2004-10-21 Yeda Research And Development Co. Ltd. Reversible pegylated drugs
CA2522345A1 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
WO2005014024A2 (en) * 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of a polymer and a protein linked by an oxime linking group
EP1654290B1 (en) 2003-08-12 2019-03-13 Lipoxen Technologies Limited Sialic acid derivatives for protein derivatisation and conjugation
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
ES2422187T3 (es) 2003-12-03 2013-09-09 Biogenerix Ag Factor estimulante de colonias de granulocitos glicopegilados
US20060040856A1 (en) 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
EP1776389B1 (en) 2004-08-12 2016-06-29 Lipoxen Technologies Limited Sialic acid derivatives
WO2006031811A2 (en) 2004-09-10 2006-03-23 Neose Technologies, Inc. Glycopegylated interferon alpha
AU2005322067B8 (en) 2004-12-27 2012-07-26 Takeda Pharmaceutical Company Limited Polymer-von Willebrand factor-conjugates
CA2611823C (en) 2005-06-16 2013-07-30 Nektar Therapeutics Al, Corporation Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
US7645860B2 (en) 2006-03-31 2010-01-12 Baxter Healthcare S.A. Factor VIII polymer conjugates
US20100056428A1 (en) 2006-09-01 2010-03-04 Novo Nordisk Health Care Ag Modified proteins
DK2101821T3 (da) 2006-12-15 2014-10-06 Baxter Healthcare Sa Faktor VIIA-(poly)sialinsyre-konjugat med forlænget halveringstid in vivo
GB0908393D0 (en) * 2009-05-15 2009-06-24 Almac Sciences Scotland Ltd Labelling method
BR112012001814A8 (pt) * 2009-07-27 2018-02-06 Baxalta GmbH Conjugados de proteína de coagulação sanguínea
EP3081233B1 (en) * 2009-07-27 2020-12-23 Baxalta GmbH Glycopolysialylation of proteins other than blood coagulation proteins
TWI534152B (zh) * 2010-07-30 2016-05-21 巴克斯特國際公司 用於肟連接的親核性催化劑
KR101560541B1 (ko) * 2012-04-13 2015-10-19 아우토리브 디벨롭먼트 아베 에어백 모듈과 스티어링 휠의 조립체
AU2013204754C1 (en) * 2012-05-16 2018-10-11 Takeda Pharmaceutical Company Limited Nucleophilic Catalysts for Oxime Linkage

Similar Documents

Publication Publication Date Title
JP2020111599A5 (cg-RX-API-DMAC7.html)
JP2022046676A5 (cg-RX-API-DMAC7.html)
JP2019116500A5 (cg-RX-API-DMAC7.html)
JP2022034075A5 (cg-RX-API-DMAC7.html)
JP2013536180A5 (cg-RX-API-DMAC7.html)
JP2019089810A5 (cg-RX-API-DMAC7.html)
TWI546279B (zh) 用於偶聯水溶性脂肪酸衍生物與蛋白質之材料及方法
JP3497175B2 (ja) 一価の(monovalent)抗体フラグメント
JP7014844B2 (ja) オキシム連結のための求核触媒
JP5933923B2 (ja) 新規な複合タンパク質及びペプチド
JP2021038256A (ja) オキシム連結のための求核触媒
WO1996010089A1 (en) Modification of peptide and protein
US8378073B2 (en) Process for attaching effector molecules to proteins
JP2011157365A5 (cg-RX-API-DMAC7.html)
EP1613644A1 (en) Peg-physiologically active polypeptide homodimer complex having prolonged in vivo half-life and process for the preparation thereof
KR20190047951A (ko) 콜로니자극인자와 폴리올이 접합된 접합물을 고수율로 제조하는 방법